Cargando…
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993923/ https://www.ncbi.nlm.nih.gov/pubmed/35395836 http://dx.doi.org/10.1038/s41408-022-00646-0 |
_version_ | 1784684007614578688 |
---|---|
author | Sureau, Léa Buors, Caroline Ianotto, Jean-Christophe Boyer, Françoise Tanguy-Schmidt, Aline Roy, Lydia Cayssials, Emilie Cailly, Laura Chomel, Jean-Claude Chauveau, Aurélie Orvain, Corentin Mansier, Olivier Ranta, Dana Robles, Margot Gyan, Emmanuel Hérault, Olivier Nimubona, Stanislas Marchand, Tony Lippert, Eric Riou, Jérémie Ugo, Valérie Luque Paz, Damien |
author_facet | Sureau, Léa Buors, Caroline Ianotto, Jean-Christophe Boyer, Françoise Tanguy-Schmidt, Aline Roy, Lydia Cayssials, Emilie Cailly, Laura Chomel, Jean-Claude Chauveau, Aurélie Orvain, Corentin Mansier, Olivier Ranta, Dana Robles, Margot Gyan, Emmanuel Hérault, Olivier Nimubona, Stanislas Marchand, Tony Lippert, Eric Riou, Jérémie Ugo, Valérie Luque Paz, Damien |
author_sort | Sureau, Léa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8993923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89939232022-04-27 JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes Sureau, Léa Buors, Caroline Ianotto, Jean-Christophe Boyer, Françoise Tanguy-Schmidt, Aline Roy, Lydia Cayssials, Emilie Cailly, Laura Chomel, Jean-Claude Chauveau, Aurélie Orvain, Corentin Mansier, Olivier Ranta, Dana Robles, Margot Gyan, Emmanuel Hérault, Olivier Nimubona, Stanislas Marchand, Tony Lippert, Eric Riou, Jérémie Ugo, Valérie Luque Paz, Damien Blood Cancer J Correspondence Nature Publishing Group UK 2022-04-08 /pmc/articles/PMC8993923/ /pubmed/35395836 http://dx.doi.org/10.1038/s41408-022-00646-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Sureau, Léa Buors, Caroline Ianotto, Jean-Christophe Boyer, Françoise Tanguy-Schmidt, Aline Roy, Lydia Cayssials, Emilie Cailly, Laura Chomel, Jean-Claude Chauveau, Aurélie Orvain, Corentin Mansier, Olivier Ranta, Dana Robles, Margot Gyan, Emmanuel Hérault, Olivier Nimubona, Stanislas Marchand, Tony Lippert, Eric Riou, Jérémie Ugo, Valérie Luque Paz, Damien JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title | JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title_full | JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title_fullStr | JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title_full_unstemmed | JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title_short | JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
title_sort | jak2 v617f polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993923/ https://www.ncbi.nlm.nih.gov/pubmed/35395836 http://dx.doi.org/10.1038/s41408-022-00646-0 |
work_keys_str_mv | AT sureaulea jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT buorscaroline jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT ianottojeanchristophe jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT boyerfrancoise jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT tanguyschmidtaline jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT roylydia jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT cayssialsemilie jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT caillylaura jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT chomeljeanclaude jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT chauveauaurelie jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT orvaincorentin jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT mansierolivier jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT rantadana jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT roblesmargot jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT gyanemmanuel jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT heraultolivier jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT nimubonastanislas jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT marchandtony jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT lipperteric jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT rioujeremie jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT ugovalerie jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes AT luquepazdamien jak2v617fpolycythemiaveraandessentialthrombocythemiadynamicclinicalfeaturesassociatedwithlongtermoutcomes |